Monday, September 26, 2011

http://ChemMol.com Products Release




Product Name: 3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid
CAS RN: 775304-57-9
ChemMol ID: 49400130
Supplier: APIchem
Supplier Products ID: API-22203
Structure:

Product Name: Pimecrolimus
CAS RN: 137071-32-0
ChemMol ID: 49400129
Supplier: APIchem
Supplier Products ID: API-26768
Structure:

Product Name: PHA-665752
CAS RN: 477575-56-7
ChemMol ID: 49400128
Supplier: APIchem
Supplier Products ID: API-147
Structure:

Product Name: Crizotinib
CAS RN: 877399-52-5
ChemMol ID: 49400127
Supplier: APIchem
Supplier Products ID: API-1615
Structure:

Product Name: Perifosine
CAS RN: 157716-52-4
ChemMol ID: 49400126
Supplier: APIchem
Supplier Products ID: API-26101
Structure:

Product Name: PD0325901
CAS RN: 870474-62-7
ChemMol ID: 49400125
Supplier: APIchem
Supplier Products ID: API-144
Structure:

Product Name: Pazopanib Hydrochloride
CAS RN: 444731-52-6
ChemMol ID: 49400124
Supplier: APIchem
Supplier Products ID: API-143
Structure:

Product Name: Obatoclax Mesylate
CAS RN: 803712-79-0
ChemMol ID: 49400123
Supplier: APIchem
Supplier Products ID: API-142
Structure:

Product Name: Nutlin-3
CAS RN: 548472-68-0
ChemMol ID: 49400122
Supplier: APIchem
Supplier Products ID: API-22770
Structure:

Product Name: Nilotinib
CAS RN: 641571-10-0
ChemMol ID: 49400121
Supplier: APIchem
Supplier Products ID: API-10473
Structure:

Product Name: Entinostat
CAS RN: 209783-80-2
ChemMol ID: 49400120
Supplier: APIchem
Supplier Products ID: API-24716
Structure:

Product Name: Motesanib Diphosphate
CAS RN: 857876-30-3
ChemMol ID: 49400119
Supplier: APIchem
Supplier Products ID: API-136
Structure:

Product Name: Masitinib
CAS RN: 790299-79-5
ChemMol ID: 49400118
Supplier: APIchem
Supplier Products ID: API-135
Structure:

Product Name: Lapatinib Ditosylate
CAS RN: 388082-78-8
ChemMol ID: 49400116
Supplier: APIchem
Supplier Products ID: API-6035
Structure:

Product Name: Panobinostat
CAS RN: 404950-80-7
ChemMol ID: 49400117
Supplier: APIchem
Supplier Products ID: API-23264
Structure:

No comments:

Post a Comment